Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 551,519 | 621,295 | 534,141 | 504,666 | 500,051 |
| Cost of Goods | 249,316 | 276,038 | 235,133 | 231,291 | 229,988 |
| Gross Profit | 302,203 | 345,257 | 299,008 | 273,375 | 270,063 |
| Operating Expenses | 258,873 | 289,315 | 260,379 | 275,367 | 244,842 |
| Operating Income | 43,646 | 55,980 | 38,762 | -1,701 | 26,209 |
| Interest Expense | 5,782 | 5,781 | 5,872 | 6,045 | 5,316 |
| Other Income | 825,825 | -4,249 | -2,302 | 8,866 | -746 |
| Pre-tax Income | 863,689 | 45,950 | 30,588 | 1,120 | 20,147 |
| Income Tax | 206,915 | -36,784 | 8,521 | -3,915 | 7,734 |
| Net Income Continuous | 656,774 | 82,734 | 22,067 | 5,035 | 12,413 |
| Net Income | $656,774 | $82,734 | $22,067 | $5,035 | $12,413 |
| EPS Basic Total Ops | 22.05 | 2.79 | 0.74 | 0.17 | 0.42 |
| EPS Basic Continuous Ops | 22.05 | 2.79 | 0.74 | 0.17 | 0.42 |
| EPS Diluted Total Ops | 21.77 | 2.76 | 0.73 | 0.17 | 0.41 |
| EPS Diluted Continuous Ops | 21.77 | 2.75 | 0.73 | 0.17 | 0.42 |
| EBITDA(a) | $43,646 | $55,980 | $74,062 | $35,299 | $59,909 |